Uncategorized
BLOG: Is the FDA finally moving forward on novel IOLs?
For many years now, a forlorn expression has crossed the faces of American doctors when a non-United States speaker approaches the podium to describe IOL designs available only in their countries.Presbyopia-correcting IOL (PC-IOL) technologies available here are beyond 10 years old and, except for Crystalens (Bausch + Lomb), we still don’t have toric PC-IOLs. And what of promising implants like the dual-optic Synchrony IOL?